schliessen

Filtern

 

Bibliotheken

2.

Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development
by WAGNER, John A

Annual review of pharmacology and toxicology, 2008, Vol.48 (1), p.631-651

4.

The Use of Biomarkers in Human Pharmacology (Phase I) Studies
by Cohen, A.F

Annual review of pharmacology and toxicology, 2015-01-06, Vol.55 (1), p.55-74

11.

Chemoprevention in Barrett's oesophagus
by Baruah, Anushka, M.D

Baillière's best practice & research. Clinical gastroenterology, 2014, Vol.29 (1), p.151-165

14.

Challenge of surrogate endpoints
by Furgerson, James L

Southern medical journal (Birmingham, Ala.), 2012-03, Vol.105 (3), p.156-160

18.

When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes
by Lemley, Kevin V

Pediatric nephrology (Berlin, West), 2010-03-30, Vol.25 (10), p.2021-2034

19.

Imaging biomarkers as surrogate endpoints for drug development
by Richter, Wolf S

European journal of nuclear medicine and molecular imaging, 2006-07, Vol.33 Suppl 1 (1), p.6-10

20.

Monitoring drug therapy
by Hitchings, Andrew W

Medicine (Abingdon. 1995, UK ed.), 2020-07, Vol.48 (7), p.456-462

123

Recommended databases

Find more Articles matching your search terms in these recommended databases.